Delivery Order SPE2DB22D3501-SPE2DB25FWY01
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $9,978.49. This non-set-aside, firm fixed-price contract is scheduled for completion by July 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $10,648.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with a completion date of August 6, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Concerta 54mg tablets (100-count units) valued at $12,350.28 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) valued at $1,899.20. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by August 14, 2025, with performance executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates as...
- On August 14, 2025, the Defense Logistics Agency awarded a delivery order valued at $21,760.03 to AmerisourceBergen Drug Corp for the supply of Concerta ER 18 mg tablets (100-count units). The contract, which is not set aside and was competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency (DLA) awarded a $3,724.82 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a single delivery against AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100 count) with a ceiling value of $5,428.87. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The product will be performed...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used in the treatment of attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $33,063.14, represents a non-set-aside competitive award and is scheduled for ultimate completion by August 8, 2025. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Concerta ER 18 mg tablets (100-count) with a ceiling value of $26,581.56. This firm fixed-price delivery order, which carries an ultimate completion date of August 11, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Concerta ER Tablets 18mg, with a ceiling value of $1,588.38. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This delivery order is issued under...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWY01Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Concerta ER 54 mg tablets in a quantity of 100 units, valued at $4,031.84 under a firm fixed-price contract. This delivery order represents a non-set-aside competitive award with an ultimate completion date of August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract derived from AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds significant standing as a critical federal vendor supplying pharmaceutical products and medical supplies to military and veteran healthcare systems. The parent IDC with DLA encompasses a wide spectrum of medications and medical commodities across multiple therapeutic domains, enabling the contractor to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Concerta ER—a medication used in the treatment of attention deficit hyperactivity disorder—exemplifies the company's role in fulfilling specialized pharmaceutical procurement requirements for the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/19/25 |